Cargando…

Antisense Oligonucleotide-Mediated Splice Switching: Potential Therapeutic Approach for Cancer Mitigation

SIMPLE SUMMARY: Splicing is an important mechanism by which precursor mRNA is modified into mature mRNA. This splicing plays a major role in the generation of different proteins required for cells. Cancer cells modulate this splicing in such a way that it facilitates uncontrolled growth and survival...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raguraman, Prithi, Balachandran, Akilandeswari Ashwini, Chen, Suxiang, Diermeier, Sarah D., Veedu, Rakesh N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583451/ https://www.ncbi.nlm.nih.gov/pubmed/34771719 http://dx.doi.org/10.3390/cancers13215555

Ejemplares similares

Antisense Oligonucleotides Targeting Angiogenic Factors as Potential Cancer Therapeutics
por: Le, Bao T., et al.
Publicado: (2018)

Alpha-l-Locked Nucleic Acid-Modified Antisense Oligonucleotides Induce Efficient Splice Modulation In Vitro
por: Raguraman, Prithi, et al.
Publicado: (2020)

Evaluation of DNA segments in 2′-modified RNA sequences in designing efficient splice switching antisense oligonucleotides
por: Le, Bao T., et al.
Publicado: (2021)

Splice-switching antisense oligonucleotides as therapeutic drugs
por: Havens, Mallory A., et al.
Publicado: (2016)

Recent Advances in Oligonucleotide Therapeutics in Oncology
por: Xiong, Haoyu, et al.
Publicado: (2021)

Therapeutically Significant MicroRNAs in Primary and Metastatic Brain Malignancies
por: Balachandran, Akilandeswari A., et al.
Publicado: (2020)

Systematic evaluation of 2′-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro
por: Chen, Suxiang, et al.
Publicado: (2019)

Author Correction: Systematic evaluation of 2′-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro
por: Chen, Suxiang, et al.
Publicado: (2020)

Novel Disulfide-Bridged Bioresponsive Antisense Oligonucleotide Induces Efficient Splice Modulation in Muscle Myotubes in Vitro
por: Le, Bao T., et al.
Publicado: (2020)

Hybridization-mediated off-target effects of splice-switching antisense oligonucleotides
por: Scharner, Juergen, et al.
Publicado: (2020)

Synthesis of a Morpholino Nucleic Acid (MNA)-Uridine Phosphoramidite, and Exon Skipping Using MNA/2′-O-Methyl Mixmer Antisense Oligonucleotide
por: Chen, Suxiang, et al.
Publicado: (2016)

Induction of cryptic pre-mRNA splice-switching by antisense oligonucleotides
por: Ham, Kristin A., et al.
Publicado: (2021)

BACE1 Inhibition Using 2’-OMePS Steric Blocking Antisense Oligonucleotides
por: Chakravarthy, Madhuri, et al.
Publicado: (2019)

Systematic Approach to Developing Splice Modulating Antisense Oligonucleotides
por: Aung-Htut, May T., et al.
Publicado: (2019)

Mismatched single stranded antisense oligonucleotides can induce efficient dystrophin splice switching
por: Fragall, Clayton T, et al.
Publicado: (2011)

The small molecule Retro-1 enhances the pharmacological actions of antisense and splice switching oligonucleotides
por: Ming, Xin, et al.
Publicado: (2013)

Targeting novel human transient receptor potential ankyrin 1 splice variation with splice-switching antisense oligonucleotides
por: Huang, Hua, et al.
Publicado: (2021)

Consequences of Making the Inactive Active Through Changes in Antisense Oligonucleotide Chemistries
por: Zaw, Khine, et al.
Publicado: (2019)

Open reading frame correction using splice-switching antisense oligonucleotides for the treatment of cystic fibrosis
por: Michaels, Wren E., et al.
Publicado: (2022)

Splice-Switching Antisense Oligonucleotides as a Targeted Intrinsic Engineering Tool for Generating Armored Redirected T Cells
por: Ceccarello, Erica, et al.
Publicado: (2021)

Antisense Oligonucleotide Mediated Splice Correction of a Deep Intronic Mutation in OPA1
por: Bonifert, Tobias, et al.
Publicado: (2016)

Overcoming imatinib resistance conferred by the BIM deletion polymorphism in chronic myeloid leukemia with splice-switching antisense oligonucleotides
por: Liu, Jun, et al.
Publicado: (2017)

Splice-Switching Antisense Oligonucleotides Reduce LRRK2 Kinase Activity in Human LRRK2 Transgenic Mice
por: Korecka, Joanna A., et al.
Publicado: (2020)

Novel Orthogonally Hydrocarbon-Modified Cell-Penetrating Peptide Nanoparticles Mediate Efficient Delivery of Splice-Switching Antisense Oligonucleotides In Vitro and In Vivo
por: Bazaz, Safa, et al.
Publicado: (2021)

Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense oligonucleotides
por: Hinrich, Anthony J, et al.
Publicado: (2016)

Rational Design of Short Locked Nucleic Acid-Modified 2′-O-Methyl Antisense Oligonucleotides for Efficient Exon-Skipping In Vitro
por: Le, Bao T., et al.
Publicado: (2017)

Therapeutic Potential of Tricyclo-DNA antisense oligonucleotides
por: Goyenvalle, Aurelie, et al.
Publicado: (2016)

Nonviral delivery systems for antisense oligonucleotide therapeutics
por: Huang, Si, et al.
Publicado: (2022)

Manipulation of PK-M mutually exclusive alternative splicing by antisense oligonucleotides
por: Wang, Zhenxun, et al.
Publicado: (2012)

RNA-Based Therapeutics: From Antisense Oligonucleotides to miRNAs
por: Bajan, Sarah, et al.
Publicado: (2020)

Thiomorpholino oligonucleotides as a robust class of next generation platforms for alternate mRNA splicing
por: Le, Bao T., et al.
Publicado: (2022)

Uncoupling Splicing From Transcription Using Antisense Oligonucleotides Reveals a Dual Role for I Exon Donor Splice Sites in Antibody Class Switching
por: Marchalot, Anne, et al.
Publicado: (2020)

Anti-tumor activity of splice-switching oligonucleotides
por: Bauman, John A., et al.
Publicado: (2010)

Antisense Oligonucleotide-Mediated Transcript Knockdown in Zebrafish
por: Pauli, Andrea, et al.
Publicado: (2015)

Towards next generation antisense oligonucleotides: mesylphosphoramidate modification improves therapeutic index and duration of effect of gapmer antisense oligonucleotides
por: Anderson, Brooke A, et al.
Publicado: (2021)

Antisense oligonucleotides correct the familial dysautonomia splicing defect in IKBKAP transgenic mice
por: Sinha, Rahul, et al.
Publicado: (2018)

Antisense oligonucleotide modulation of non-productive alternative splicing upregulates gene expression
por: Lim, Kian Huat, et al.
Publicado: (2020)

Reduction of integrin alpha 4 activity through splice modulating antisense oligonucleotides
por: Aung-Htut, May T., et al.
Publicado: (2019)

Therapeutic antisense oligonucleotides against cancer: hurdling to the clinic
por: Moreno, Pedro M. D., et al.
Publicado: (2014)

Cerebral Organoids and Antisense Oligonucleotide Therapeutics: Challenges and Opportunities
por: Lange, Jenny, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9u319k6mlsprlu7d8pafaqng2n